The following amendment(s) has (have) been made to the 'Transaction in Own Shares' announcement released on 2 November 2026 at (13.45 UKT) under RNS No 4615B.
References to Goldman Sachs International have been amended to Merrill Lynch International.
All other details remain unchanged.
The full amended text is shown below.
British American Tobacco p.l.c.
2 November 2026
TRANSACTION IN OWN SHARES
British American Tobacco p.l.c. (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 15 April 2026 it purchased the following number of its ordinary shares of 25 pence each ("Shares") from Merrill Lynch International during the period from 26 October 2026 to 30 October 2026 as part of its buyback programme announced on 18 March 2024:
|
Date of purchase: |
26 October 2026 |
27 October 2026 |
28 October 2026 |
29 October 2026 |
30 October 2026 |
|
Number of ordinary shares of 25 pence each purchased: |
120,127 |
120,446 |
111,875 |
124,853 |
119,523 |
|
Highest price paid per share (pence): |
4,532.00p |
4,505.00p |
4,523.00p |
4,546.00p |
4,641.00p |
|
Lowest price paid per share (pence): |
4,418.00p |
4,445.00p |
4,476.00p |
4,489.00p |
4,571.00p |
|
Volume weighted average price paid per share (pence): |
4,497.65p |
4,486.75p |
4,505.18p |
4,520.09p |
4,595.90p |
The Company intends to cancel the purchased Shares.
Following the purchase and cancellation of these Shares, the Company will have 2,154,726,588 ordinary shares in issue (excluding treasury shares) which carry voting rights and will hold 132,647,849 ordinary shares in treasury. This information may be used by shareholders to determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a schedule of individual trades carried out by Merrill Lynch International during the period set out above is detailed in the attached:
http://www.rns-pdf.londonstockexchange.com/rns/4615B_1-2026-11-2.pdf
http://www.rns-pdf.londonstockexchange.com/rns/4615B_2-2026-11-2.pdf
http://www.rns-pdf.londonstockexchange.com/rns/4615B_3-2026-11-2.pdf
http://www.rns-pdf.londonstockexchange.com/rns/4615B_4-2026-11-2.pdf
http://www.rns-pdf.londonstockexchange.com/rns/4615B_5-2026-11-2.pdf
Enquiries:
Investor Relations
Victoria Buxton | [email protected]
Schedule of purchases - aggregate information
|
Issuer name |
ISIN Code |
Transaction date |
Daily total volume (in number of shares) |
Daily weighted average price of shares acquired |
Platform |
|
British American Tobacco p.l.c. |
GB0002875804 |
26/10/2026 |
120,127 |
4,497.65p |
LSE |
|
British American Tobacco p.l.c. |
GB0002875804 |
26/10/2026 |
0 |
0p |
CHIX |
|
British American Tobacco p.l.c. |
GB0002875804 |
26/10/2026 |
0 |
0p |
BATE |
|
British American Tobacco p.l.c. |
GB0002875804 |
27/10/2026 |
120,446 |
4,486.75p |
LSE |
|
British American Tobacco p.l.c. |
GB0002875804 |
27/10/2026 |
0 |
0p |
CHIX |
|
British American Tobacco p.l.c. |
GB0002875804 |
27/10/2026 |
0 |
0p |
BATE |
|
British American Tobacco p.l.c. |
GB0002875804 |
28/10/2026 |
111,875 |
4,505.18p |
LSE |
|
British American Tobacco p.l.c. |
GB0002875804 |
28/10/2026 |
0 |
0p |
CHIX |
|
British American Tobacco p.l.c. |
GB0002875804 |
28/10/2026 |
0 |
0p |
BATE |
|
British American Tobacco p.l.c. |
GB0002875804 |
29/10/2026 |
124,853 |
4,520.09p |
LSE |
|
British American Tobacco p.l.c. |
GB0002875804 |
29/10/2026 |
0 |
0p |
CHIX |
|
British American Tobacco p.l.c. |
GB0002875804 |
29/10/2026 |
0 |
0p |
BATE |
|
British American Tobacco p.l.c. |
GB0002875804 |
30/10/2026 |
119,523 |
4,595.90p |
LSE |
|
British American Tobacco p.l.c. |
GB0002875804 |
30/10/2026 |
0 |
0p |
CHIX |
|
British American Tobacco p.l.c. |
GB0002875804 |
30/10/2026 |
0 |
0p |
BATE |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.